Leaflet CEFOTAXIMA ATB 1g powder for parenteral solution
Indicated for: bacterial infections
Route of administration: parenteral
Substance: cefotaxime (cephalosporin antibiotic)
ATC: J01DD01 (Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins)
Dose adjustment may be needed in kidney disease.
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Seek medical advice if severe or persistent diarrhea occurs.
Cefotaxime is a third-generation cephalosporin antibiotic used to treat severe bacterial infections, including meningitis, pneumonia, intra-abdominal infections, urinary tract infections, and sepsis. It is effective against a wide range of gram-negative and gram-positive bacteria.
The medication is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection, the patient's weight, and renal function. Cefotaxime is often used in hospitals for complicated infections or for patients at high risk of severe infections.
Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or renal toxicity. It is important for patients to complete the treatment as directed by their doctor.
Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as anaphylactic shock or hematological disorders. Patients should inform their doctor of any unusual symptoms.
General data about CEFOTAXIMA ATB 1g
- Substance: cefotaxime
- Date of latest medicines list: 01-07-2014
- Product code: W01082002
- Concentration: 1g
- Pharmaceutical form: powder for parenteral solution
- Quantity: 50
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for cefotaxime
- 0.5g
- 1g
- 2g
- 500mg